ETROLIZUMAB TREATMENT INCREASES BLOOD LEVELS OF CD3, TREG AND TH17 CELLS MEASURED THROUGH EPIGENETIC ACTIVATION OF THE CD3, FOXP3 AND IL-17 LOCI

Franklin Fuh  1     Eva Raschke  2     Akiko Chai  1     Caroline Looney  1     Thomas Oliver Kleen  2     Severine Vermeire  3     Sharon O'Byrne  4     Teresa Ramirez Montagut    
1 Genentech Inc.,South San Francisco, CA,United States
2 Epiontis GmbH,Berlin,Germany
3 Division of Gastroenterology,University of Leuven,Leuven,Belgium
4 Genentech Inc.,South San Francisco, CA,United S

Conference
UEG Week 2015

Citation
United European Gastroenterology Journal; 2015: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing